Melbourne biomedical researchers, as the University of Melbourne and Monash University, have received$ 4.2 million( £3.1 million) to carry out the clinical trials....
The trial,?...
which is going to be conducted over six months by Northern Hospital in collaboration with Oxford University, will focus on heparin, a widely used blood-thinning drug. Australianresearchers believe that spraying a blood-thinning drug into the nose could offer protection against Covid. Heparin is used to treat or pre
综合
每日快报-科学
2021-12-30 00:00:00.0